Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT01937546What this trial is testingThe Effect of Primary Delivery of the Anterior Compared With the Posterior Shoulder on Perineal Trauma: a Randomized Controlled TrialWho this might be right forBirth Injuries Holbaek Sygehus 650
Large-scale testing (Phase 3)UnknownNCT05374252What this trial is testingChemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma PatientsWho this might be right forAnal Canal Cancer Stage IIIAnal Squamous Cell CarcinomaAnal Canal Cancer+1 more Sixth Affiliated Hospital, Sun Yat-sen University 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Not applicableStudy completedNCT03465501What this trial is testingInterstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose RatesWho this might be right forAnal Canal Cancer Institut Paoli-Calmettes 89
Testing effectiveness (Phase 2)Study completedNCT02701088What this trial is testingStudy of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of LifeWho this might be right forLocally Advanced Anal Canal Cancer Centre Francois Baclesse 71
Testing effectiveness (Phase 2)Study completedNCT05060471What this trial is testingPD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA PatientsWho this might be right forAnal Canal CancerAnal Squamous Cell CarcinomaAnal Cancer+3 more Sun Yat-sen University 25
Testing effectiveness (Phase 2)Study completedNCT01941966What this trial is testingSubstitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.Who this might be right forAnal Canal Cancer. Instituto do Cancer do Estado de São Paulo 51
Testing effectiveness (Phase 2)UnknownNCT02560298What this trial is testingCisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal CancerWho this might be right forAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Squamous Cell Carcinoma+4 more ECOG-ACRIN Cancer Research Group 91
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02314169What this trial is testingNivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal CancerWho this might be right forAnal Canal Squamous Cell CarcinomaMetastatic Anal Canal CarcinomaStage IV Anal Cancer AJCC v8 National Cancer Institute (NCI) 143
Not applicableNot Yet RecruitingNCT07059442What this trial is testingScreening for Anal Cancer and Precancer in Women With HIV (SANCA)Who this might be right forAnal Canal Cancer Karolinska Institutet 1,000
Testing effectiveness (Phase 2)Study completedNCT04505553What this trial is testingOral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal CancerWho this might be right forAppendix CarcinomaColon CarcinomaEsophageal Carcinoma+10 more University of Washington 78
Early research (Phase 1)Study completedNCT00003046What this trial is testingInterleukin-12 in Treating Patients With Cancer in the AbdomenWho this might be right forAnal CancerColorectal CancerGallbladder Cancer+2 more M.D. Anderson Cancer Center 29